Cross-validation and cross-study validation of chronic lymphocytic leukaemia with exome sequences and machine learning Online publication date: Fri, 14-Oct-2016
by Abdulrhman Aljouie; Nihir Patel; Bharati Jadhav; Usman Roshan
International Journal of Data Mining and Bioinformatics (IJDMB), Vol. 16, No. 1, 2016
Abstract: The era of genomics brings the potential of better DNA-based risk prediction and treatment. We explore this problem for chronic lymphocytic leukaemia that is one of the largest whole exome data set available from the NIH dbGaP database. We perform a standard next-generation sequence procedure to obtain Single-Nucleotide Polymorphism (SNP) variants and obtain a peak mean accuracy of 82% in our cross-validation study. We also cross-validate an Affymetrix 6.0 genome-wide association study of the same samples where we find a peak accuracy of 57%. We then perform a cross-study validation with exome samples from other studies in the NIH dbGaP database serving as the external data set. There we obtain an accuracy of 70% with top Pearson ranked SNPs obtained from the original exome data set. Our study shows that even with a small sample size we can obtain moderate to high accuracy with exome sequences, which is encouraging for future work.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Data Mining and Bioinformatics (IJDMB):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook